HeartFlow, Inc. (HTFL)
NASDAQ: HTFL · Real-Time Price · USD
30.55
-1.18 (-3.72%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.

Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart’s arteries.

The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies.

Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests.

HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009.

The company was incorporated in 2007 and is headquartered in Mountain View, California.

HeartFlow, Inc.
HeartFlow logo
Country United States
Founded 2007
IPO Date Aug 8, 2025
Industry Health Information Services
Sector Healthcare
Employees 843
CEO John Farquhar

Contact Details

Address:
331 E. Evelyn Avenue
Mountain View, California 94041
United States
Phone 650 241 1221
Website heartflow.com

Stock Details

Ticker Symbol HTFL
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $19.00
CIK Code 0001464521
CUSIP Number 42238D107
ISIN Number US42238D1072
Employer ID 26-0506743
SIC Code 3841

Key Executives

Name Position
John C.M. Farquhar President, Chief Executive Officer and Director
Vikram Verghese C.F.A. Chief Financial Officer
Dr. Campbell D.K. Rogers FACC, M.D. Chief Medical Officer and Executive Vice President
Dr. John Henry Stevens M.D. Co-Founder
Kathleen Carey Senior Vice President of Operations
Mhairi L. Jones Chief Accounting Officer
Justin Cambra Chief Technology Officer
Nicholas S. Laudico Vice President of Investor Relations
Angela Ahmad J.D. Chief Legal and Compliance Officer
Shivanth Bhaskaran Senior Vice President of Marketing, International Sales and Customer Success

Latest SEC Filings

Date Type Title
Apr 10, 2026 144 Filing
Apr 1, 2026 144 Filing
Mar 31, 2026 SCHEDULE 13G Filing
Mar 19, 2026 144 Filing
Mar 18, 2026 S-8 Securities to be offered to employees in employee benefit plans
Mar 18, 2026 10-K Annual Report
Mar 18, 2026 8-K Current Report
Mar 18, 2026 144 Filing
Mar 10, 2026 144 Filing
Mar 5, 2026 SCHEDULE 13G/A Filing